Literature DB >> 3804028

Deduction of duodenal ulcer recurrence by healing with cimetidine plus sulpiride.

M Tatsuta, H Iishi, S Okuda.   

Abstract

The effect of combined treatment with sulpiride plus cimetidine was compared against that of cimetidine alone on the healing of duodenal ulcer and on the subsequent relapse rate. In a double blind study, 35 patients with duodenal ulcer diagnosed by endoscopy were randomly assigned to receive cimetidine 800 mg daily and 38 patients to receive cimetidine 800 mg plus sulpiride 200 mg daily. Sixty patients whose ulcers were healed at three months continued to be observed after stopping treatment and underwent endoscopy to detect recurrences when symptomatic or at three and at six months if asymptomatic. Recurrence was observed in 18 (72%) of 25 patients whose ulcers had healed on cimetidine alone, but in only 11 (38%) of 29 patients whose ulcers healed on cimetidine plus sulpiride.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3804028      PMCID: PMC1433988          DOI: 10.1136/gut.27.12.1512

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  17 in total

1.  Perforation of chronic peptic ulcers after cimetidine.

Authors:  W A Wallace; C M Orr; A R Bearn
Journal:  Br Med J       Date:  1977-10-01

2.  Inhibition of gastrin secretion by sulpiride treatment in duodenal ulcer patients.

Authors:  R Caldara; M Romussi; C Ferrari
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

3.  Relapse of duodenal ulceration after cimetidine treatment.

Authors:  M Guslandi; M Cambielli; L Bierti; A Tittobello
Journal:  Br Med J       Date:  1978-03-18

4.  A controlled study comparing cimetidine treatment to an intensive antacid regimen in the therapy of uncomplicated duodenal ulcer.

Authors:  G Fedeli; M Anti; G L Rapaccini; I De Vitis; A Butti; I M Civello
Journal:  Dig Dis Sci       Date:  1979-10       Impact factor: 3.199

5.  Prevention of duodenal ulcers in the rat using a combination of ranitidine and sucralphate in subtherapeutic doses.

Authors:  S Bank; H Zimmerman; C Smolow; V Kranz
Journal:  Gut       Date:  1985-06       Impact factor: 23.059

6.  Prophylactic effect of cimetidine in duodenal ulcer disease.

Authors:  E Gudmand-Høyer; K B Jensen; E Krag; J Rask-Madsen; I Rahbek; S J Rune; H R Wulff
Journal:  Br Med J       Date:  1978-04-29

7.  Cimetidine versus intensive antacid therapy for duodenal ulcer: a multicenter trial.

Authors:  A F Ippoliti; R A Sturdevant; J I Isenberg; M Binder; R Camacho; R Cano; C Cooney; M M Kline; R L Koretz; J H Meyer; I M Samloff; A D Schwabe; E A Strom; J E Valenzuela; R H Wintroub
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

8.  Treatment of duodenal ulcer with antacid and sulpiride. A double-blind controlled study.

Authors:  S K Lam; K C Lam; C L Lai; C K Yeung; L Y Yam; W S Wong
Journal:  Gastroenterology       Date:  1979-02       Impact factor: 22.682

9.  Maintenance treatment of recurrent peptic ulcer by cimetidine.

Authors:  G Bodemar; A Walan
Journal:  Lancet       Date:  1978-02-25       Impact factor: 79.321

10.  Smoking and cancer of the alimentary tract in Poland.

Authors:  J Staszewski
Journal:  Br J Cancer       Date:  1969-06       Impact factor: 7.640

View more
  3 in total

1.  Gastric and duodenal anti-ulcer activity of sulpiride, a dopamine D2 receptor antagonist, in rats.

Authors:  J K Desai; N S Parmar
Journal:  Agents Actions       Date:  1994-10

2.  Time-delimited signaling of MET receptor tyrosine kinase regulates cortical circuit development and critical period plasticity.

Authors:  Ke Chen; Xiaokuang Ma; Antoine Nehme; Jing Wei; Yan Cui; Yuehua Cui; Dezhong Yao; Jie Wu; Trent Anderson; Deveroux Ferguson; Pat Levitt; Shenfeng Qiu
Journal:  Mol Psychiatry       Date:  2020-01-03       Impact factor: 15.992

3.  Risks of Sulpiride-Induced Parkinsonism in Peptic Ulcer and Gastroesophageal Reflux Disease Patients in Taiwan: A Nationwide Population-Based Study.

Authors:  Cheng-Yu Wei; I-Shiang Tzeng; Mei-Chen Lin; Yung-Hsiang Yeh; Chung Y Hsu; Woon-Man Kung
Journal:  Front Pharmacol       Date:  2020-04-24       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.